Treatment of pediatric relapsed and refractory acute myeloid leukemia

Background. Despite the modern therapy programs including hematopoietic stem cell transplantation, the treatment outcomes for children with acute myeloid leukemia (AML) remain unsatisfactory. The 5‑year overall survival rate is about 70 %. The 5‑year overall survival rate for patients with relapsed...

Full description

Saved in:
Bibliographic Details
Main Authors: F. A. Makhacheva, T. T. Valiev
Format: Article
Language:Russian
Published: ABV-press 2023-05-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/815
Tags: Add Tag
No Tags, Be the first to tag this record!